Prevalence of Genetic Disorders and GLUT1 Deficiency in a Ketogenic Diet Clinic

Stacy Hewson, Ledia Brunga, Matilde Fernandez Ojeda, Elizabeth Imhof, Jaina Patel, Maria Zak, Elizabeth J. Donner, Jeff Kobayashi, Gajja S. Salomons, Saadet Mercimek-Andrews

    Research output: Contribution to journalArticleAcademicpeer-review

    3 Citations (Scopus)

    Abstract

    Between July of 2012 and December of 2014, 39 patients were enrolled prospectively to investigate the prevalence of glucose transporter 1 (GLUT1) deficiency in a ketogenic diet clinic. None of them had GLUT1 deficiency. All patients seen in the same clinic within the same period were reviewed retrospectively. A total of 18 of these 85 patients had a genetic diagnosis, including GLUT1 deficiency, pathogenic copy number variants, congenital disorder of glycosylation, neuronal ceroid lipofuscinosis type II, mitochondrial disorders, tuberous sclerosis, lissencephaly, and SCN1A-, SCN8A-, and STXBP1-associated epileptic encephalopathies. The prevalence of genetic diagnoses was 21% and prevalence of GLUT1 deficiency was 2.4% in our retrospective cohort study.
    Original languageEnglish
    Pages (from-to)93-96
    JournalCanadian journal of neurological sciences. Le journal canadien des sciences neurologiques
    Volume45
    Issue number1
    DOIs
    Publication statusPublished - 2018

    Cite this